Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate to implement such a switch. Methods. Forty-one stable Prograf (Astellas) re...

Full description

Bibliographic Details
Main Authors:	Fernando González, René López, Elizabeth Arriagada, René Carrasco, Natalia Gallardo, Eduardo Lorca
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Journal of Transplantation
Online Access:	http://dx.doi.org/10.1155/2017/5646858

Similar Items

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
by: Seung Seok Han, et al.
Published: (2016-01-01)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
by: Rita R Alloway, et al.
Published: (2017-11-01)

Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
by: Hyunmin Ko, et al.
Published: (2021-03-01)

Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
by: Piotr Giza, et al.
Published: (2020-06-01)

Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients
by: Saeed Alqahtani, et al.
Published: (2021-01-01)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01)

Safe conversion to cicloral, a generic cylosporine, in both stable and De Novo renal transplant recipients
by: Kahn Delawir, et al.
Published: (2010-01-01)

Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
by: Yukuang Guo, MS, et al.
Published: (2020-10-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients
by: Choi HJ, et al.
Published: (2018-02-01)

Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients
by: Lars Pape, et al.
Published: (2011-01-01)

Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
by: Samuel Chan, et al.
Published: (2017-01-01)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
by: Kinga Krzyżowska, et al.
Published: (2018-01-01)

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients.
by: Nynke M Kannegieter, et al.
Published: (2018-01-01)

The Effect of Maintenance Treatment with Twice-Daily or Prolonged Once-Daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients
by: Aureliusz Kolonko, et al.
Published: (2020-06-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.
by: Markus Riegersperger, et al.
Published: (2019-01-01)

Effect of cyclosporin and tacrolimus on kidney function in liver recipients
by: Elena D. Kosmacheva, et al.
Published: (2018-09-01)

Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
by: Hee-Yeon Jung, et al.
Published: (2020-01-01)

Impact of Conversion From Advagraf to Twice-Daily Generic Tacrolimus in Kidney Transplant Recipients: A Single-Center Study—A 3-Year Follow-Up
by: Iolanda Godinho, MD, et al.
Published: (2017-07-01)

Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: Cost minimization and potential metabolic benefits
by: Sarra Elamin, et al.
Published: (2014-01-01)

Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
by: Shruti Gupta, et al.
Published: (2018-01-01)

Massive pleural effusion in a renal transplant recipient on tacrolimus
by: L S Nayagam, et al.
Published: (2014-01-01)

Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients
by: Jae Hyun Kim, et al.
Published: (2019-08-01)

Fatal Lactic Acidosis in a Kidney Transplant Recipient on Combination Antiretroviral Therapy after Initiation of Tacrolimus Therapy
by: Michael V. Holmes, et al.
Published: (2011-01-01)

Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients
by: Grizzle, A.J, et al.
Published: (2021)

The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients
by: Hooper, David K.
Published: (2010)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Gut microbiota and tacrolimus dosing in kidney transplantation.
by: John R Lee, et al.
Published: (2015-01-01)

Tacrolimus-Induced Hyponatremia in Lung Transplant Recipients: A Case Series
by: Paul N. Banks, MA, et al.
Published: (2018-04-01)

Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients
by: Arin S. Jantz, et al.
Published: (2013-01-01)

Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
by: Sofue T, et al.
Published: (2014-02-01)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.
by: Opas Traitanon, et al.
Published: (2019-01-01)

Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis
by: Chen L, et al.
Published: (2021-09-01)

Switching Immunosuppressive Drugs in Kidney Transplant Recipients: "Show Me the Evidence"
by: Ansari Mohammed, et al.
Published: (2006-01-01)

Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
by: Simon Ball
Published: (2017-11-01)

Cannot write session to /tmp/vufind_sessions/sess_sl7qn5kjqdtk27s28m26a16q6d